Skip to main content

Table 6 Physicochemical properties of oxindole–benzothiazole hybrids 9ar from SwissADME [35]

From: Oxindole–benzothiazole hybrids as CDK2 inhibitors and anticancer agents: design, synthesis and biological evaluation

Compound ID

MW

#Rotatable bonds

#H-bond acceptors

#H-bond donors

MR

TPSA

iLOGP

BBB permeant

Pgp substrate

Lipinski #violations

Bioavailability score

Synthetic accessibility

9a

428.46

6

5

2

122.66

120.92

3.08

No

No

0

0.55

3.42

9b

442.49

6

5

2

127.63

120.92

3.29

No

No

0

0.55

3.55

9c

458.49

7

6

2

129.15

130.15

2.81

No

No

0

0.55

3.6

9d

473.46

7

7

2

131.48

166.74

2.42

No

No

0

0.55

3.57

9e

462.91

6

5

2

127.67

120.92

2.93

No

No

0

0.55

3.4

9f

507.36

6

5

2

130.36

120.92

2.88

No

No

1

0.55

3.49

9g

458.49

7

6

2

129.15

130.15

2.69

No

No

0

0.55

3.57

9h

472.52

7

6

2

134.12

130.15

3.02

No

No

0

0.55

3.7

9i

488.52

8

7

2

135.65

139.38

3.23

No

No

0

0.55

3.77

9j

503.49

8

8

2

137.98

175.97

2.36

No

No

2

0.17

3.72

9k

492.93

7

6

2

134.16

130.15

3.09

No

No

0

0.55

3.56

9l

537.39

7

6

2

136.85

130.15

3.34

No

No

1

0.55

3.64

9m

458.49

7

6

2

129.15

130.15

3.39

No

No

0

0.55

3.52

9n

472.52

7

6

2

134.12

130.15

3.52

No

No

0

0.55

3.65

9o

488.52

8

7

2

135.65

139.38

3.26

No

No

0

0.55

3.71

9p

503.49

8

8

2

137.98

175.97

2.5

No

No

2

0.17

3.67

9q

492.93

7

6

2

134.16

130.15

3.25

No

No

0

0.55

3.51

9r

537.39

7

6

2

136.85

130.15

3.42

No

No

1

0.55

3.59